AAAAAA

   
Results: 1-10 |
Results: 10
Diagnosis and prognostic markers of HCMV infection
Authors: Grangeot-Keros, L Cointe, D
Citation: L. Grangeot-keros et D. Cointe, Diagnosis and prognostic markers of HCMV infection, J CLIN VIRO, 21(3), 2001, pp. 213-221
Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR
Authors: Gouarin, S Palmer, P Cointe, D Rogez, S Vabret, A Rozenberg, F Denis, F Freymuth, F Lebon, P Grangeot-Keros, L
Citation: S. Gouarin et al., Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR, J CLIN VIRO, 21(1), 2001, pp. 47-55
Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity
Authors: Baccard-Longere, M Freymuth, F Cointe, D Seigneurin, JM Grangeot-Keros, L
Citation: M. Baccard-longere et al., Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity, CL DIAG LAB, 8(2), 2001, pp. 429-431
Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) Study
Authors: Emilie, D Burgard, M Lascoux-Combe, C Laughlin, M Krzysiek, R Pignon, C Rudent, A Molina, JM Livrozet, JM Souala, F Chene, G Grangeot-Keros, L Galanaud, P Sereni, D Rouzioux, C
Citation: D. Emilie et al., Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) Study, AIDS, 15(11), 2001, pp. 1435-1437
Preferential and persistent depletion of CCR5(+) T-helper lymphocytes withnonlymphoid homing potential despite early treatment of primary HIV infection
Authors: Krzysiek, R Rudent, A Bouchet-Delbos, L Foussat, A Boutillon, C Portier, A Ingrand, D Sereni, D Galanaud, P Grangeot-Keros, L Emilie, D
Citation: R. Krzysiek et al., Preferential and persistent depletion of CCR5(+) T-helper lymphocytes withnonlymphoid homing potential despite early treatment of primary HIV infection, BLOOD, 98(10), 2001, pp. 3169-3171
Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus
Authors: Llorente, L Richaud-Patin, Y Garcia-Padilla, C Claret, E Jakez-Ocampo, J Cardiel, MH Alcocer-Varela, J Grangeot-Keros, L Alarcon-Segovia, D Wijdenes, J Galanaud, P Emilie, D
Citation: L. Llorente et al., Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus, ARTH RHEUM, 43(8), 2000, pp. 1790-1800
Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995
Authors: Belanger, P Derouin, F Grangeot-Keros, L Meyer, L
Citation: P. Belanger et al., Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995, CLIN INF D, 28(3), 1999, pp. 575-581
Microbiology in sudden infant death syndrome (SIDS) and other childhood deaths
Authors: Rambaud, C Guibert, M Briand, E Grangeot-Keros, L Coulomb-L'Hermine, A Dehan, M
Citation: C. Rambaud et al., Microbiology in sudden infant death syndrome (SIDS) and other childhood deaths, FEMS IM MED, 25(1-2), 1999, pp. 59-66
Re-emergence of rubella during pregnancy: 11 cases in Clermont-Ferrand in 1997
Authors: Henquell, C Bournazeau, JA Vanlieferinghen, P Grangeot-Keros, L Chambon, M Lebel, A Lemery, D Peigue-Lafeuille, H
Citation: C. Henquell et al., Re-emergence of rubella during pregnancy: 11 cases in Clermont-Ferrand in 1997, PRESSE MED, 28(15), 1999, pp. 777-780
Should we routinely screen for cytomegalovirus antibody during pregnancy?
Authors: Grangeot-Keros, L Simon, B Audibert, F Vial, M
Citation: L. Grangeot-keros et al., Should we routinely screen for cytomegalovirus antibody during pregnancy?, INTERVIROLO, 41(4-5), 1998, pp. 158-162
Risultati: 1-10 |